cell lines raw264 7 atcc cat Search Results


99
ATCC cell lines raw 264 7 atcc cat
Cell Lines Raw 264 7 Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm30122557-371-99-103?v=ATCC
Average 99 stars, based on 1 article reviews
cell lines raw 264 7 atcc cat - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

94
CLS Cell Lines Service GmbH cell line raw264 7
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Cell Line Raw264 7, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pmc07443466-97-13-16?v=CLS+Cell+Lines+Service+GmbH
Average 94 stars, based on 1 article reviews
cell line raw264 7 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

86
Ubigene Biosciences Co Ltd raw264 7 cells
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264 7 Cells, supplied by Ubigene Biosciences Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pmc12549075-69-1-21?v=Ubigene+Biosciences+Co+Ltd
Average 86 stars, based on 1 article reviews
raw264 7 cells - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Procell Inc raw264 7 cell medium
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264 7 Cell Medium, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/10__2147_slash_jir__s545787-48-0-7?v=Procell+Inc
Average 86 stars, based on 1 article reviews
raw264 7 cell medium - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Korean Cell Line Bank raw 264 7 macrophages
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw 264 7 Macrophages, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm41389505-44-10-13?v=Korean+Cell+Line+Bank
Average 86 stars, based on 1 article reviews
raw 264 7 macrophages - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics raw264.7 mouse macrophages
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264.7 Mouse Macrophages, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm39923106-59-0-5?v=iCell+Gene+Therapeutics
Average 90 stars, based on 1 article reviews
raw264.7 mouse macrophages - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures murine macrophage cell line raw 264.7
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Murine Macrophage Cell Line Raw 264.7, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/10__3390_slash_molecules25133022-264-0-13?v=European+Collection+of+Authenticated+Cell+Cultures
Average 90 stars, based on 1 article reviews
murine macrophage cell line raw 264.7 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
ATCC raw264 7 cells
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm37152710-98-4-19?v=ATCC
Average 92 stars, based on 1 article reviews
raw264 7 cells - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

86
Genechem raw264 7 cell lines lentivirus lv hif1a carrying sirna
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264 7 Cell Lines Lentivirus Lv Hif1a Carrying Sirna, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm41207266-158-4-13?v=Genechem
Average 86 stars, based on 1 article reviews
raw264 7 cell lines lentivirus lv hif1a carrying sirna - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

94
ATCC raw 264 7
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw 264 7, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pmc09542434-100-0-2?v=ATCC
Average 94 stars, based on 1 article reviews
raw 264 7 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology 22117 rrid ab 2300956
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
22117 Rrid Ab 2300956, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pmc08961232-11-8-4?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
22117 rrid ab 2300956 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
DS Pharma Biomedical raw264.7 cells
Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs <t>and</t> <t>RAW264.7</t> cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05
Raw264.7 Cells, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+raw264+7+atcc+cat/pm30451856-324-9-14?v=DS+Pharma+Biomedical
Average 90 stars, based on 1 article reviews
raw264.7 cells - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs and RAW264.7 cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05

Journal: British Journal of Pharmacology

Article Title: Artesunate interacts with the vitamin D receptor to reverse sepsis‐induced immunosuppression in a mouse model via enhancing autophagy

doi: 10.1111/bph.15158

Figure Lengend Snippet: Artesunate (AS) increases pro‐inflammatory cytokines release and bacterial clearance within LPS‐tolerant macrophages (n = 4). (a) LPS increased the release of TNF‐α (a1) and IL‐6 (a2) from peritoneal macrophages (PMs) in a dose‐dependent manner. (b) Schematic diagram of the establishment of the LPS‐tolerant macrophage model. (c) The level of TNF‐α (c1) and IL‐6 (c2) in LPS‐tolerant PMs (n = 5). (d) Effect of AS (5, 10 and 20 μg·ml−1) treatment on the level of TNF‐α (d1, d2) and IL‐6 (d3, d4) in LPS‐tolerant PMs and RAW264.7 cells (n = 5). (e) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant RAW264.7 cells (n = 8). (f) Effect of AS (20 μg·ml−1) treatment on the mRNA level of TNF‐α (f1, f2) and IL‐6 (f3, f4) in LPS‐tolerant THP‐1 monocytes and THP‐1 derived macrophages (n = 5). (g) Effect of AS treatment (20 μg·ml−1) on the bacterial load in LPS‐tolerant THP‐1 derived macrophages (n = 8). One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05

Article Snippet: Cell lines, culture and isolation of peritoneal macrophages from mice The murine macrophage‐like cell line RAW264.7 (CLS Cat#400319/p462_RAW‐2647, RRID:CVCL_0493) cells and human monocyte THP‐1 (CLS Cat# 300356/p804_THP‐1, RRID:CVCL_0006) cells were purchased from the American Type Culture Collection (Manassas, VA, USA).

Techniques: Derivative Assay

The vitamin D receptor is predicted to be an interactor candidate of artesunate (AS). (a) A total of 20 underlying signal molecules were selected via the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP). (b) Effect of AS on the relative mRNA levels of Vdr (n = 5). (c) Effect of AS on the protein levels of VDR (n = 5). (d) Effect of Vdr siRNA (d1) and Vdr‐KD lentiviral vector (d2) on TNF‐α levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (e) Effect of Vdr‐OE lentiviral vector on TNF‐α level in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (f1) Schematic diagram of the binding assay designed in our laboratory. (f2) Effect of VD3 on the binding of AS and VDR tracked by AS fluorophores (n = 5). AS with fluorophore 12‐(7‐oxycoumarinyl‐ethoxy) dihydroartemisinin was named AS I and AS with 12‐(‐1H‐benzo [de] isoquinoline‐1, 3(2H)‐dione‐2‐ethoxy) dihydroartemisinin was named AS II. (g) Effect of VD3 (100 nM) on TNF‐α levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Journal: British Journal of Pharmacology

Article Title: Artesunate interacts with the vitamin D receptor to reverse sepsis‐induced immunosuppression in a mouse model via enhancing autophagy

doi: 10.1111/bph.15158

Figure Lengend Snippet: The vitamin D receptor is predicted to be an interactor candidate of artesunate (AS). (a) A total of 20 underlying signal molecules were selected via the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP). (b) Effect of AS on the relative mRNA levels of Vdr (n = 5). (c) Effect of AS on the protein levels of VDR (n = 5). (d) Effect of Vdr siRNA (d1) and Vdr‐KD lentiviral vector (d2) on TNF‐α levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (e) Effect of Vdr‐OE lentiviral vector on TNF‐α level in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (f1) Schematic diagram of the binding assay designed in our laboratory. (f2) Effect of VD3 on the binding of AS and VDR tracked by AS fluorophores (n = 5). AS with fluorophore 12‐(7‐oxycoumarinyl‐ethoxy) dihydroartemisinin was named AS I and AS with 12‐(‐1H‐benzo [de] isoquinoline‐1, 3(2H)‐dione‐2‐ethoxy) dihydroartemisinin was named AS II. (g) Effect of VD3 (100 nM) on TNF‐α levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Article Snippet: Cell lines, culture and isolation of peritoneal macrophages from mice The murine macrophage‐like cell line RAW264.7 (CLS Cat#400319/p462_RAW‐2647, RRID:CVCL_0493) cells and human monocyte THP‐1 (CLS Cat# 300356/p804_THP‐1, RRID:CVCL_0006) cells were purchased from the American Type Culture Collection (Manassas, VA, USA).

Techniques: Plasmid Preparation, Binding Assay

Artesunate (AS) inhibits the nuclear translocation of VDR and modulates the transcription of its target gene Atg16l1. RAW264.7 cells were treated as described in the legend of Figure 2d. (a) Immunoblotting to observe the VDR level in the nuclear lysate. (b) Immunostaining to observe the nuclear translocation of VDR. VDR was probed using Alexa Fluor 555 (red). Representative images (bar = 5 μm) (b1). The karyoplasmic ratio of VDR was quantified from 100 cells (normalized to medium) (b2). (c) ChIP analysis for the binding of VDR to the Atg16l1 promoter. The protein–DNA complex was immunoprecipitated with anti‐VDR antibody or a negative control IgG. Representative agarose gels for the VDR‐binding region in the Atg16l1 promoter and Actb DNA in the input amplified using semiquantitative PCR. (d) The binding of VDR to the Atg16l1 promoter, normalized to Actb DNA in the input, analysed by qPCR (n = 5). (e) The protein level of ATG16L1 in LPS‐tolerant RAW264.7 cells treated with AS. (f) Change in ATG16L1 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐KD) treated with AS. (g) Change in ATG16L1 protein levels in Vdr‐OE LPS‐tolerant RAW264.7 cells treated with AS. One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05

Journal: British Journal of Pharmacology

Article Title: Artesunate interacts with the vitamin D receptor to reverse sepsis‐induced immunosuppression in a mouse model via enhancing autophagy

doi: 10.1111/bph.15158

Figure Lengend Snippet: Artesunate (AS) inhibits the nuclear translocation of VDR and modulates the transcription of its target gene Atg16l1. RAW264.7 cells were treated as described in the legend of Figure 2d. (a) Immunoblotting to observe the VDR level in the nuclear lysate. (b) Immunostaining to observe the nuclear translocation of VDR. VDR was probed using Alexa Fluor 555 (red). Representative images (bar = 5 μm) (b1). The karyoplasmic ratio of VDR was quantified from 100 cells (normalized to medium) (b2). (c) ChIP analysis for the binding of VDR to the Atg16l1 promoter. The protein–DNA complex was immunoprecipitated with anti‐VDR antibody or a negative control IgG. Representative agarose gels for the VDR‐binding region in the Atg16l1 promoter and Actb DNA in the input amplified using semiquantitative PCR. (d) The binding of VDR to the Atg16l1 promoter, normalized to Actb DNA in the input, analysed by qPCR (n = 5). (e) The protein level of ATG16L1 in LPS‐tolerant RAW264.7 cells treated with AS. (f) Change in ATG16L1 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐KD) treated with AS. (g) Change in ATG16L1 protein levels in Vdr‐OE LPS‐tolerant RAW264.7 cells treated with AS. One‐way ANOVA followed by Tukey's post hoc test; * P < 0.05

Article Snippet: Cell lines, culture and isolation of peritoneal macrophages from mice The murine macrophage‐like cell line RAW264.7 (CLS Cat#400319/p462_RAW‐2647, RRID:CVCL_0493) cells and human monocyte THP‐1 (CLS Cat# 300356/p804_THP‐1, RRID:CVCL_0006) cells were purchased from the American Type Culture Collection (Manassas, VA, USA).

Techniques: Translocation Assay, Western Blot, Immunostaining, Binding Assay, Immunoprecipitation, Negative Control, Amplification

Artesunate's (AS) effect is autophagy‐dependent through VDR in vitro. (a) Effect of Atg16l1 siRNA on TNF‐α (a1) and IL‐6 (a2) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (b) Effect of bafilomycin (Baf) (10 ng·ml−1) on TNF‐α (b1) and IL‐6 (b1) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (c) Effect of 3‐MA (5 mM) on TNF‐α (c1) and IL‐6 (c2) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (d) Effect of 3‐MA, Ly294002 (10 μM), or Baf on the bacterial clearance in LPS‐tolerant RAW264.7 cells treated with AS (n = 8). (e1) LPS increased the protein levels of LC3B‐I, LC3B‐II and ATG5 in a dose‐dependent manner in RAW264.7 cells. (e2) The protein levels of LC3B‐I, LC3B‐II and ATG5 over time in RAW264.7 cells treated with LPS (100 ng·ml−1). The level of expression peaked at 1 h. (f) Representative image of immunofluorescence staining of LC3B in LPS‐tolerant RAW264.7 cells treated with AS (bar = 2 μm). (f1) Relative fluorescent puncta indicating LC3B aggregation were quantified from 100 cells; the number in the medium group was normalized as 1 (f2). (g) The protein levels of LC3B‐II, ATG16L1 and ATG5 in LPS‐tolerant RAW264.7 cells treated with AS. (h) Changes in LC3B‐II, ATG16L1 and ATG5 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐KD) treated with AS. (i) Changes in LC3B‐II, ATG16L1 and ATG5 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐OE) treated with AS. One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Journal: British Journal of Pharmacology

Article Title: Artesunate interacts with the vitamin D receptor to reverse sepsis‐induced immunosuppression in a mouse model via enhancing autophagy

doi: 10.1111/bph.15158

Figure Lengend Snippet: Artesunate's (AS) effect is autophagy‐dependent through VDR in vitro. (a) Effect of Atg16l1 siRNA on TNF‐α (a1) and IL‐6 (a2) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (b) Effect of bafilomycin (Baf) (10 ng·ml−1) on TNF‐α (b1) and IL‐6 (b1) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (c) Effect of 3‐MA (5 mM) on TNF‐α (c1) and IL‐6 (c2) levels in LPS‐tolerant RAW264.7 cells treated with AS (n = 5). (d) Effect of 3‐MA, Ly294002 (10 μM), or Baf on the bacterial clearance in LPS‐tolerant RAW264.7 cells treated with AS (n = 8). (e1) LPS increased the protein levels of LC3B‐I, LC3B‐II and ATG5 in a dose‐dependent manner in RAW264.7 cells. (e2) The protein levels of LC3B‐I, LC3B‐II and ATG5 over time in RAW264.7 cells treated with LPS (100 ng·ml−1). The level of expression peaked at 1 h. (f) Representative image of immunofluorescence staining of LC3B in LPS‐tolerant RAW264.7 cells treated with AS (bar = 2 μm). (f1) Relative fluorescent puncta indicating LC3B aggregation were quantified from 100 cells; the number in the medium group was normalized as 1 (f2). (g) The protein levels of LC3B‐II, ATG16L1 and ATG5 in LPS‐tolerant RAW264.7 cells treated with AS. (h) Changes in LC3B‐II, ATG16L1 and ATG5 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐KD) treated with AS. (i) Changes in LC3B‐II, ATG16L1 and ATG5 protein levels in LPS‐tolerant RAW264.7 cells (Vdr‐OE) treated with AS. One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Article Snippet: Cell lines, culture and isolation of peritoneal macrophages from mice The murine macrophage‐like cell line RAW264.7 (CLS Cat#400319/p462_RAW‐2647, RRID:CVCL_0493) cells and human monocyte THP‐1 (CLS Cat# 300356/p804_THP‐1, RRID:CVCL_0006) cells were purchased from the American Type Culture Collection (Manassas, VA, USA).

Techniques: In Vitro, Expressing, Immunofluorescence, Staining

Artesunate (AS) inhibits the physical interaction between VDR and NF‐κB p65 in LPS‐tolerant macrophages. RAW264.7 cells were treated as described in the legend of Figure 2d. (a) The cytoplasm (a1) and nuclear (a2) lysate were used for an IP experiment using anti‐VDR antibodies and the associated NF‐κB p65 (p65) was detected by immunoblotting (IB). (b) Immunostaining to observe the co‐localization of p65 and VDR. p65 was probed using Alexa Fluor 488 (green). VDR was probed using Alexa Fluor 555 (red). Representative images are shown (bar = 5 μm) (b1). The co‐localization of VDR and p65 (b2) and the karyoplasmic ratio of p65 (b3) was quantified from 100 cells (normalized to medium). (c) The p65 level in the nuclear lysate was detected using elisa and WB. (d) Change in the p65 level in Vdr‐KD (d1) or Vdr‐OE (d2) LPS‐tolerant RAW264.7 cells treated with AS. (e) Change in the TNF‐α level in p65‐KD (e1) or p65‐OE (e2) LPS‐tolerant RAW264.7 cells treated with AS (n = 5). One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Journal: British Journal of Pharmacology

Article Title: Artesunate interacts with the vitamin D receptor to reverse sepsis‐induced immunosuppression in a mouse model via enhancing autophagy

doi: 10.1111/bph.15158

Figure Lengend Snippet: Artesunate (AS) inhibits the physical interaction between VDR and NF‐κB p65 in LPS‐tolerant macrophages. RAW264.7 cells were treated as described in the legend of Figure 2d. (a) The cytoplasm (a1) and nuclear (a2) lysate were used for an IP experiment using anti‐VDR antibodies and the associated NF‐κB p65 (p65) was detected by immunoblotting (IB). (b) Immunostaining to observe the co‐localization of p65 and VDR. p65 was probed using Alexa Fluor 488 (green). VDR was probed using Alexa Fluor 555 (red). Representative images are shown (bar = 5 μm) (b1). The co‐localization of VDR and p65 (b2) and the karyoplasmic ratio of p65 (b3) was quantified from 100 cells (normalized to medium). (c) The p65 level in the nuclear lysate was detected using elisa and WB. (d) Change in the p65 level in Vdr‐KD (d1) or Vdr‐OE (d2) LPS‐tolerant RAW264.7 cells treated with AS. (e) Change in the TNF‐α level in p65‐KD (e1) or p65‐OE (e2) LPS‐tolerant RAW264.7 cells treated with AS (n = 5). One‐way ANOVA followed by Tukey's post hoc test; ns, not significant; * P < 0.05

Article Snippet: Cell lines, culture and isolation of peritoneal macrophages from mice The murine macrophage‐like cell line RAW264.7 (CLS Cat#400319/p462_RAW‐2647, RRID:CVCL_0493) cells and human monocyte THP‐1 (CLS Cat# 300356/p804_THP‐1, RRID:CVCL_0006) cells were purchased from the American Type Culture Collection (Manassas, VA, USA).

Techniques: Western Blot, Immunostaining, Enzyme-linked Immunosorbent Assay